NCT06206512View on ClinicalTrials.gov

Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions
Heart FailureOveractive BladderIncontinence
Interventions
DRUG

Extended release torsemide

This is an extended-release formulation of torsemide

DRUG

Immediate release torsemide

This is the generic, immediate release formulation of torsemide

DRUG

Extended release torsemide placebo

Placebo of extended release torsemide

DRUG

Immediate release torsemide placebo

Placebo of immediate release torsemide

Trial Locations (1)

75390

RECRUITING

Cardiometabolic Research Unit, Dallas

All Listed Sponsors
lead

Sarfez Pharmaceuticals, Inc.

INDUSTRY